We accelerate the present.ㅤWe build the future.
The future isn’t a distant promise.
At CyberLabs, it’s the result of consistent execution.
We bring management, governance, and technology into businesses, closing the gap between the future and the present.
About the Cyberlabs Group
CyberLabs was founded in 2018. Our mission is to drive business performance through cutting-edge technology and management, impacting millions of people every day as we consume, interpret, and create technology.technologies
Portfolio Companies
PSafe Technology specializes in developing cybersecurity and technology solutions. Its focus is to provide products and services to protect devices and data against online threats. With over 10 years of authority and recognition, the company operates ensuring the security of systems and information.
Akad Seguros is the union of CyberLabs and GP Investments to reinvent the insurance industry in Brazil. Akad is an insurer of commercial risks, especially Transport, E&O, D&O, Corporate, Warranty and Cyber. Through its digital platform, Akad empowers more than 13,000 brokers to sell better. Exit
Sinatra.pro is an AI Observability and Agentic Hub platform built specifically for enterprise e-commerce and omnichannel retail. The company uses proprietary artificial intelligence to monitor complex store operations in real time, helping large brands detect and fix systemic errors before they impact revenue or customer experience.
r4Solution is a platform that processes royalty reports, automatically calculates splits among all parties involved, and makes direct payments to each rights holder in a secure, organized, and transparent manner.
An AI-powered sales platform and agent infrastructure for B2B teams that automates the entire sales cycle, including prospecting, meetings, and training via specialized agents. It utilizes integrated, real-time tools to optimize performance across channels in a secure, organized, and transparent manner.
Gcell 3D is a Brazilian deep-tech company based in Rio de Janeiro and incubated at COPPE/UFRJ, specializing in three-dimensional (3D) cell culture and tissue bioengineering. Founded in 2019, it focuses on producing human tissues in the laboratory for pharmaceutical and cosmetic testing, as well as for regenerative medicine.

Let’s build the future together